Literature DB >> 15003288

The Ets transcription factor Fev is specifically expressed in the human central serotonergic neurons.

Philippe Maurer1, Sandrine Rorive, Alban de Kerchove d'Exaerde, Serge N Schiffmann, Isabelle Salmon, Yvan de Launoit.   

Abstract

In the mouse and the rat brain, the Ets transcription factor pet-1 is exclusively expressed in the central serotonin (5-hydroxytryptaminergic: 5-HT) system. In pet-1 null mice, the defect of this factor induces early disruption of the 5-HT function, resulting in an increase in anxiety and aggression; thus indicating its pivotal role in this system. Here, we studied the expression of fev, the homologue of pet-1, in the human brain. We showed that this transcription factor is exclusively expressed in the midline part of the human brainstem containing raphe nuclei, which also specifically expressed 5-HT transporter (sert) and tryptophan hydroxylase (tph), two markers of the 5-HT neurotransmitter system. This clearly suggests that fev is expressed in human serotonergic neurons. While the deficiency of the central serotonergic signaling is a major factor involved in the development of some psychiatric disorders, Fev could be a good diagnosis marker as well as a good target for pharmacological treatments of these patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003288     DOI: 10.1016/j.neulet.2003.12.086

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Region-specific regulation of 5-HT1A receptor expression by Pet-1-dependent mechanisms in vivo.

Authors:  Kirsten X Jacobsen; Margaret Czesak; Mariam Deria; Brice Le François; Paul R Albert
Journal:  J Neurochem       Date:  2011-01-24       Impact factor: 5.372

2.  A differentially autoregulated Pet-1 enhancer region is a critical target of the transcriptional cascade that governs serotonin neuron development.

Authors:  Michael M Scott; Katherine C Krueger; Evan S Deneris
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 3.  Serotonergic transcriptional networks and potential importance to mental health.

Authors:  Evan S Deneris; Steven C Wyler
Journal:  Nat Neurosci       Date:  2012-02-26       Impact factor: 24.884

4.  GPR30 is necessary for estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the rat hypothalamus.

Authors:  C E McAllister; R D Creech; P A Kimball; N A Muma; Q Li
Journal:  Psychoneuroendocrinology       Date:  2012-01-20       Impact factor: 4.905

5.  The expression of the transcription factor FEV in adult human brain and its association with affective disorders.

Authors:  Claudia B Kriegebaum; Lise Gutknecht; Lena Bartke; Andreas Reif; Henriette N Buttenschon; Ole Mors; Klaus-Peter Lesch; Angelika G Schmitt
Journal:  J Neural Transm (Vienna)       Date:  2010-05-18       Impact factor: 3.575

Review 6.  Insights into the complex influence of 5-HT signaling on thalamocortical axonal system development.

Authors:  Esmee S B van Kleef; Patricia Gaspar; Alexandre Bonnin
Journal:  Eur J Neurosci       Date:  2012-05       Impact factor: 3.386

Review 7.  Molecular genetics of mouse serotonin neurons across the lifespan.

Authors:  E S Deneris
Journal:  Neuroscience       Date:  2011-08-30       Impact factor: 3.590

Review 8.  Serotonin gene variants are unlikely to play a significant role in the pathogenesis of the sudden infant death syndrome.

Authors:  David S Paterson
Journal:  Respir Physiol Neurobiol       Date:  2013-07-10       Impact factor: 1.931

9.  Serotonin-related FEV gene variant in the sudden infant death syndrome is a common polymorphism in the African-American population.

Authors:  Kevin G Broadbelt; Melissa A Barger; David S Paterson; Ingrid A Holm; Elisabeth A Haas; Henry F Krous; Hannah C Kinney; Kyriacos Markianos; Alan H Beggs
Journal:  Pediatr Res       Date:  2009-12       Impact factor: 3.756

Review 10.  Medullary serotonin defects and respiratory dysfunction in sudden infant death syndrome.

Authors:  David S Paterson; Gerard Hilaire; Debra E Weese-Mayer
Journal:  Respir Physiol Neurobiol       Date:  2009-05-27       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.